Patient and Clinician Perspectives on Preventive Therapy for Migraine

Global Burden of Migraine

Use of Preventive Migraine Medication in the United States: AMPP Study

Need for New Migraine Prevention Therapies

The Real-Life Patient: History

The Real-Life Patient: At Age 17

The Real-Life Patient: How Often Does She Experience Migraine Symptoms?

The Real-Life Patient: How Many Preventive Therapies Has She Tried Over the years?

The Real-Life Patient: How Has Migraine Affected Other Aspects of Your Life?

The Real-Life Patient: How Has Migraine Affected Your Work Life?

The Real-Life Patient: How Has Stigma Affected You?

The Nurse Practitioner Perspective: How Common Is Daily Migraine?

The Patient Advocate Perspective: What Are the Barriers?

American Migraine Foundation: Priorities and Initiatives

Patients Contributing to Research: Registries

Attitudes Toward New Treatments Among the Migraine Patient Community

Biologics: mAbs vs Small Molecules

Role of the Nurse Practitioner

Role of the Nurse Practitioner (cont)

Barriers to Effective Care

Patient Experience: Barriers to Effective Care

Anti-CGRP mAbs for Migraine Prevention: Efficacy and Safety Overview

Considerations for Treatment Choice

Patient Experience With First mAb

Experience With mAbs in Clinical Practice

Concluding Remarks

Concluding Remarks (cont)

Abbreviations